Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | TK1 | P04183 | 3/20 | 0.65 |
| ▸ | TYMS | P04818 | 3/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8529362 | 1.00 | POLB (0.67) | POLBTK1TYMS | |
| SCHEMBL16130860 | 1.00 | POLB (0.67) | POLBTK1TYMS | |
| SCHEMBL31300315 | 0.99 | POLB (0.66) | POLBTK1TYMS | |
| SCHEMBL17231067 | 0.99 | POLB (0.66) | POLBTK1TYMS | |
| SCHEMBL29350121 | 0.99 | POLB (0.66) | POLBTK1TYMS | |
| SCHEMBL17231073 | 0.99 | POLB (0.66) | POLBTK1TYMS | |
| SCHEMBL20987570 | 0.99 | POLB (0.66) | POLBTK1TYMS | |
| SCHEMBL20987563 | 0.99 | POLB (0.66) | POLBTK1TYMS | |
| SCHEMBL20987562 | 0.99 | POLB (0.66) | POLBTK1TYMS | |
| SCHEMBL29352780 | 0.99 | POLB (0.66) | POLBTK1TYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4547250-A1 | METHODS AND COMPOSITIONS RELATING TO CONTROLLING PSYCHEDELIC EFFECTS WITH SEROTONIN RECEPTOR MODULATORS | Terran Biosciences Inc. (US) | 2025-05-07 | — | — | EP | disclosed |
| US-12269818-B2 | Analogs of xanomeline | TERRAN BIOSCIENCES INC. (US) | 2025-04-08 | — | — | US | disclosed |
| US-20240368149-A1 | ANALOGS OF XANOMELINE | TERRAN BIOSCIENCES INC. | 2024-11-07 | — | — | US | disclosed |
| CN-115909779-B | Vehicle bottom support early warning method and vehicle | 海信集团控股股份有限公司 | 2024-07-19 | — | — | CN | disclosed |
| US-20240197681-A1 | METHODS AND COMPOSITIONS RELATING TO PSYCHEDELICS AND SEROTONIN RECEPTOR MODULATORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-06-20 | — | — | US | disclosed |
| CN-117331389-B | Control system and method of intelligent cabinet and intelligent cabinet | 广东海新智能厨房股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118048374-A | Construction and application of RNAi gene interference system and RNA editing system based on Cas6e | 中国科学院天津工业生物技术研究所 | 2024-05-17 | — | — | CN | disclosed |
| EP-4313030-A1 | METHODS AND COMPOSITIONS RELATING TO PSYCHEDELICS AND SEROTONIN RECEPTOR MODULATORS | Terran Biosciences, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| CN-117437763-A | Environment monitoring system based on big data of internet of things | 河南大立科技有限责任公司 | 2024-01-23 | — | — | CN | disclosed |
| US-20240000795-A1 | METHODS AND COMPOSITIONS RELATING TO CONTROLLING PSYCHEDELIC EFFECTS WITH SEROTONIN RECEPTOR MODULATORS | TERRAN BIOSCIENCES INC. | 2024-01-04 | — | — | US | disclosed |
| WO-2024006984-A1 | METHODS AND COMPOSITIONS RELATING TO CONTROLLING PSYCHEDELIC EFFECTS WITH SEROTONIN RECEPTOR MODULATORS | TERRAN BIOSCIENCES INC. (US) | 2024-01-04 | — | — | WO | disclosed |
| WO-2023129976-A1 | SALT AND SOLID FORMS OF KETANSERIN | TERRAN BIOSCIENCES, INC. (US) | 2023-07-06 | — | — | WO | disclosed |
| CN-116019934-A | Enhanced delivery of viral particles to striatum and cortex | 建新公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-110178122-B | Data synchronous repair method of distributed storage system and storage medium | 深圳花儿数据技术有限公司 | 2022-10-21 | — | — | CN | disclosed |
| WO-2022212854-A1 | METHODS AND COMPOSITIONS RELATING TO PSYCHEDELICS AND SEROTONIN RECEPTOR MODULATORS | TERRAN BIOSCIENCES INC. (US) | 2022-10-06 | — | — | WO | disclosed |
| CN-114129529-A | Cinacalcet-calcitol tablet and preparation method thereof | 卓和药业集团股份有限公司 | 2022-03-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240000795-A1 | METHODS AND COMPOSITIONS RELATING TO CONTROLLING PSYCHEDELIC EFFECTS WITH SEROTONIN RECEPTOR MODULATORS | HTR2A, HTR1A, HTR2C | POLB 3423/4885TK1 1584/4885TYMS 2370/4885 |
| US-20240197681-A1 | METHODS AND COMPOSITIONS RELATING TO PSYCHEDELICS AND SEROTONIN RECEPTOR MODULATORS | HTR1A, HTR2A, HTR3A | POLB 3686/4885TK1 1515/4885TYMS 1537/4885 |
| US-20240368149-A1 | ANALOGS OF XANOMELINE | HTR5A, HTR3A, HTR3B | POLB 4042/4885TK1 2053/4885TYMS 1896/4885 |
| US-12269818-B2 | Analogs of xanomeline | HTR5A, HTR3A, HTR3B | POLB 4042/4885TK1 2053/4885TYMS 1896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.